Source comparison
Selank Amidate Immune Protocol: Dosing Schedule Comparison
Acute (7–14 days) 300mcg once daily Intranasal Salivary IgA, mucosal IL-10 5–7 days for measurable shift Best for short-term stress-immune studies; limited systemic reach Standard (28 days) 600mcg once daily Subcutaneous Th1/Th2 ratio, TNF-alpha, IL-6 10–14 da
This comparison does not assign a generated winner or score.
- Acute (7–14 days)
- 300mcg once daily
- Intranasal
- Salivary IgA, mucosal IL-10
- 5–7 days for measurable shift
- Best for short-term stress-immune studies; limited systemic reach
- Standard (28 days)
- 600mcg once daily
- Subcutaneous
- Th1/Th2 ratio, TNF-alpha, IL-6
- 10–14 days for cytokine rebalancing
- Gold standard for immune modulation research; allows full regulatory cascade development
- Extended (60 days)
- 300mcg twice daily (morning/evening)
- Chronic inflammatory markers, CRP
- 21–28 days for sustained anti-inflammatory effects
- Suitable for chronic dysregulation models; receptor sensitivity may require cycling
- CNS-Immune (21 days)
- Microglial activation markers, brain-derived cytokines
- 7–10 days for CNS immune response
- Specialized application; requires CSF or brain tissue analysis for validation